Vancouver, British Columbia (FSCwire) - Viridium Pacific Group Ltd.
(“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce that its wholly owned subsidiary, Experion
Biotechnologies Inc. (“Experion”), has received an amended license from Health Canada allowing for the production and possession
of cannabis oil. The license permits Experion to purchase oils, create oils through the extraction process, conduct formulations,
and destroy and store finished goods.
This licensing achievement is the key first step for Experion to participate in the cannabis derivatives market,
which currently involves products such as basic oils and dosed gel capsules for medical purposes, and future recreational
products, including edibles, distillates for vaporizer devices, infused beverages, and non-ingested products, such as topical
creams and lotions.
Experion will start to produce cannabis oil within its current facility located in Mission, British Columbia and
expects to become production capable with an oil processing sales license under the Cannabis Act in early 2019, in time for the
expected legalization of edibles and infused beverages for the adult use market in Canada.
Mr. Jarrett Malnarich, Viridium CEO, commented, "We believe that a great deal of the next generation of cannabis
products will be designed around cannabis extracts. Experion has achieved another important licensing milestone with the
extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis
company, operating across Canadian and international markets.”
About Viridium
Viridium Pacific Group Ltd. is a consumer wellness and biotech innovation company based in British Columbia, and
the parent company of operating subsidiaries involved in horticultural production, (Experion Biotechologies Inc.) property
development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.) Experion Biotechnologies Inc., is
a Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.
More information about Viridium can be found under the Company's profile on SEDAR at www.sedar.com.
For further information:
Viridium Pacific Group Ltd.
Jarrett Malnarich
Tel: (604) 837-8688
info@viridiumpacific.com
www.viridiumpacific.com
Renmark Financial Communications Inc.
Melanie Barbeau: mbarbeau@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com
Disclosure
This press release contains forward-looking information within the meaning of Canadian securities laws.
Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to
be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend,
estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company
cautions investors that any forward-looking information provided by the Company are not guarantees of future results or
performance, and that actual results may differ materially from those in forward looking information as a result of various
factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market
volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the
risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is
referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and
Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through
the Company page on SEDAR at www.sedar.com.
To view the original release, please click here
Source: Viridium Pacific Group Ltd. (TSX Venture:VIR, OTC Pink:VIRFF)
To follow Viridium Pacific Group Ltd. on your favorite social media platform or financial websites, please click on the icons
below.
Maximum News Dissemination by FSCwire. https://www.fscwire.com
Copyright © 2018 FSCwire